Market Overview

UPDATE: Stifel Nicolaus Downgrades VCA Antech to Sell on Long-Term Lab Headwinds

Related WOOF
Canaccord Fireside Chat Takeaways For Abaxis, Heska
Benzinga's M&A Chatter for Monday February 29, 2016

Stifel Nicolaus downgraded VCA Antech (NASDAQ: WOOF) from Hold to Sell.

Stifel Nicolaus noted, "Our work uncovers what we believe are long-term systemic issues at the high margin lab business (estimated 35%-40% of total company operating profit) which may result in continued market share losses. With VCA trading at the upper end of its three-year NTM P/E range, we believe the stock's performance will lag going forward. … While some of VCA's long-term lab challenges have been well vetted (no lab/point-of-care ("POC") bundle, lack of specialty tests, etc.), our work uncovers a potentially more troubling headwind. We believe VCA's animal hospital presence is alienating other veterinary practices from using VCA's high margin reference lab. This issue is likely to continue (if not worsen) as VCA continues to build out its hospital network."

VCA Antech closed at $21.95 on Friday.

Latest Ratings for WOOF

Jul 2016JefferiesMaintainsHold
Apr 2016CL KingInitiates Coverage onBuy
Feb 2016Credit SuisseInitiates Coverage onOutperform

View More Analyst Ratings for WOOF
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Downgrades Intraday Update Analyst Ratings


Related Articles (WOOF)

View Comments and Join the Discussion!